Indication:
CABANIB capsules, containing 20mg of Cabozantinib, are prescribed for the treatment of various cancer types, including kidney, thyroid, and liver cancers.

Pharmacology:
Cabozantinib, found in CABANIB capsules, is classified as a tyrosine kinase inhibitor. It functions by inhibiting specific enzymes involved in cancer cell growth and spread, particularly those influencing angiogenesis and the tumor microenvironment. By impeding these processes, Cabozantinib aids in halting tumor progression and metastasis.

Dosage and Administration:
The typical recommendation for CABANIB capsules is an oral intake once daily, either with or without food. The precise dosage may differ based on individual factors like weight, tolerance, and cancer type. Adjustments or pauses in dosage might be necessary based on treatment response and the occurrence of adverse effects.

Interaction:
Cabozantinib can interact with various medications, including other tyrosine kinase inhibitors and drugs metabolized by cytochrome P450 enzymes. Patients should inform their healthcare provider about all medications, supplements, and herbal products they are taking to avoid potential interactions.

Side Effects:
Common adverse effects of CABANIB capsules may include diarrhea, fatigue, nausea, reduced appetite, and elevated blood pressure. More severe reactions such as liver toxicity, low platelet count, and gastrointestinal perforation are also possible. Patients should promptly report any severe or persistent side effects to their healthcare provider.

Precautions and Warnings:
Patients taking CABANIB capsules should undergo regular monitoring of blood pressure, liver function, and thyroid function. Use of Cabozantinib during pregnancy can lead to fetal harm, necessitating contraception for both genders during treatment and a period afterward. Breastfeeding is discouraged while using CABANIB.

Overdose Effects:
In instances of CABANIB capsule overdose, patients might experience intensified adverse effects like hypertension, gastrointestinal issues, and bleeding. Management typically involves supportive care and monitoring for complications. Immediate medical attention is recommended if an overdose is suspected.